Trine Lembrecht Jørgensen

Exposure–Response Relationship of Dostarlimab in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis 2 of Part 1 of the RUBY Trial

Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Angela Jain et autres

ie, dk, se, us, ua, by, il, be, fi (code pays fourni par la source)

Safety, tolerability, and preliminary anti-tumor activity of the CX3CR1 antagonist KAND567 in combination with carboplatin in recurrent epithelial ovarian cancer: results from the phase 1b/2a KANDOVA trial

Hanna Dahlstrand, Magnus Frödin-Bolling, Anthoula Koliadi, Johan Bring et autres

se, us, dk, no (code pays fourni par la source)

Addressing geriatric oncology in Danish cancer guidelines to meet future challenges

Katharina Skovhus, Kristian Kirkelund Bentsen, Lone Winther Lietzen, Trine Lembrecht Jørgensen et autres

dk (code pays fourni par la source)

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy—the DANGER-emesis study

Sönke Detlefsen, Ditte S. Andersen, A. O. Knudsen, Trine Jakobi Nøttrup et autres

dk (code pays fourni par la source)

Association between Geriatric 8 frailty, guideline treatment, treatment adherence, and overall survival in older patients with cancer (PROGNOSIS-G8).

Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Jesper Ryg, Cecilia Margareta Lund et autres

dk (code pays fourni par la source)

2611 AI and the art of saving time: AI-based delineations in brachytherapy treatment planning. A paired prospective study.

Maximilian Konrad, Carsten Brink, Irene Hazell, Anja Ør Knudsen et autres

Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial

Elizabeth Lokich, Trine Lembrecht Jørgensen, Destin Black, David Cibula et autres

us, dk, cz, ca, my, gb (code pays fourni par la source)

Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY

Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André et autres

ie, dk, se, fr, us, ua, es, by, il, be (code pays fourni par la source)

Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study

Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Cecilia Margareta Lund, Sören Möller et autres

dk (code pays fourni par la source)

Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment: The PROGNOSIS-RCT study

Ann-Kristine Weber Giger, Helena Møgelbjerg Ditzel, Marianne Ewertz, Henrik J. Ditzel et autres

dk (code pays fourni par la source)

Development and feasibility of an exercise therapy intervention for older women with advanced epithelial ovarian cancer referred to neoadjuvant chemotherapy prior to possible interval debulking surgery

Eva Jespersen, Cristina Daviu Cobián, Trine Lembrecht Jørgensen, Lisbeth Rosenbek Minet et autres

dk (code pays fourni par la source)

Time course of adverse events in primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial.

Elizabeth Lokich, Trine Lembrecht Jørgensen, Destin Black, David Cibula et autres

us, dk, cz, ca, it, gb (code pays fourni par la source)